Communicable Disease

Communicable Disease

Communicable and Infectious diseases kill one in three people worldwide; in developing regions, they are responsible for over half of all deaths. Finding ways to prevent, treat and cure them will have a profound impact on health worldwide.

Key Initiatives, Research Partners

Grand Challenges in Global Health

Funded by the Bill & Melinda Gates Foundation, Grand Challenges in Global Health encompasses 43 project across 33 countries, working toward scientific breakthroughs to prevent, treat and cure diseases that kill millions each year.

Key Initiatives, Research Partners

MAL-ED: A Global Network for the Study of Malnutrition and Enteric Diseases

Poor nutrition is linked to more than half of all child deaths worldwide. This initiative, funded by the Bill & Melinda Gates Foundation, draws together an international group of scientific investigators to study the inter-relationship between enteric infections and malnutrition to reduce its devastating effects.

Key Initiatives, Research Partners

HIV Vaccine Development

The Foundation for the NIH's portfolio of HIV/AIDS research projects, all part of Gates Foundation's Collaboration for AIDS Vaccine Discovery, is working to expedite development of an effective AIDS vaccine.

Program, Research Partners

HIT-TB: Identification of High-quality HITs for Tuberculosis

The HIT-TB project is a collaboration between the FNIH and the National Institute of Allergy and Infectious Diseases, along with academic institutions in the United Kingdom and South Africa, and is supported by a grant from the Bill & Melinda Gates Foundation. Its focus is on combating tuberculosis, which infects one-third of the world’s population.

Program, Research Partners

Vector-based Control of Transmission: Discovery Research (VCTR)

VCTR logoThe “Vector-based Control of Transmission: Discovery Research” program is an extension of the Grand Challenges in Global Health initiative, aimed at establishing a pipeline of innovative new tools that will be safe, easily deployed, effective and sustainable for u

Program, Research Partners

Centralized Envelope Comparative Immunogenicity Study (CECI)

This project aims to address a fundamental problem blocking the development of a successful HIV-1 vaccine. The goal is to understand how best to design T cell immunogens to address the broad genetic diversity of HIV-1.

Completed Programs, Program

Path Youth Program HIV/AIDS in Adolescents

Improving the health and well being of HIV-positive and at-risk youth is the goal of the Physical/Psychosocial Advocacy & Treatment For HIV Youth Program (PATH). This multi-disciplinary collaboration of experienced HIV researchers and care providers was established by Children’s Memorial Hospital and Howard Brown Community Health Center to conduct research on the north side of Chicago.

Completed Programs, Program

Human Papilloma Virus Clinical Trial

Human papilloma virus (HPV) is the primary cause of cervical cancer. With more than $6 million in support from the Foundation for NIH, investigators have expanded the scope of an existing National Cancer Institute (NCI) Phase III clinical trial examining a vaccine intended to prevent cervical and other cancers caused by this virus. The expansion makes possible validation, regulatory support and quality-assurance monitoring of the vaccine. The goal is to ensure that the resulting discoveries can be quickly translated into therapies that will prevent the spread of HPV.

Related News
Aneesh Chopra Joins 2010 mHealth Summit as Keynote Speaker
2010 mHealth Summit Attracts Leaders in Wireless Health Research and Technology